ES2144357B1 - Procedimiento para la obtencion del analogo de somatostatina octreotide. - Google Patents

Procedimiento para la obtencion del analogo de somatostatina octreotide.

Info

Publication number
ES2144357B1
ES2144357B1 ES009800162A ES9800162A ES2144357B1 ES 2144357 B1 ES2144357 B1 ES 2144357B1 ES 009800162 A ES009800162 A ES 009800162A ES 9800162 A ES9800162 A ES 9800162A ES 2144357 B1 ES2144357 B1 ES 2144357B1
Authority
ES
Spain
Prior art keywords
procedure
obtaining
octreotide
peptide
trt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES009800162A
Other languages
English (en)
Other versions
ES2144357A1 (es
Inventor
Obiols Berta Ponsati
Farres Gemma Jodas
Poblet Marc Canas
Rodriguez Francisco J Clemente
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BCN Peptides SA
Original Assignee
Lipotec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec SA filed Critical Lipotec SA
Priority to ES009800162A priority Critical patent/ES2144357B1/es
Priority to DE69915160T priority patent/DE69915160T2/de
Priority to ES99500012T priority patent/ES2217717T3/es
Priority to EP99500012A priority patent/EP0953577B1/en
Priority to US09/240,145 priority patent/US6346601B1/en
Publication of ES2144357A1 publication Critical patent/ES2144357A1/es
Application granted granted Critical
Publication of ES2144357B1 publication Critical patent/ES2144357B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procedimiento para la obtención del análogo de somatostatina octreotide por medio de síntesis en fase sólida sobre soportes poliméricos y por intervención de grupos protectores del tipo Fmoc/tBu. Comprende construir el péptido lineal de 7 aminoácidos Boc-D-Phe-Cys(Trt)-Phe-D- Trp-Lys(Boc)Thr(tBu)-Cys(Trt)-Cl-tritil-R en donde R es un polímero; tratar con ácido la peptidil-resina resultante, para el desanclaje del péptido de la resina; ciclar la estructuras lineal obtenida por reacción con yodo antes o después de la incorporación en el extremo carboxi terminal del residuo de treoninol; incorporar el residuo de treoninol en solución sobre el péptido de 7 aminoácidos protegido con o sin el disulfuro formado; y desproteger las cadenas laterales con ácido para obtener octreotide.
ES009800162A 1998-01-29 1998-01-29 Procedimiento para la obtencion del analogo de somatostatina octreotide. Expired - Lifetime ES2144357B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES009800162A ES2144357B1 (es) 1998-01-29 1998-01-29 Procedimiento para la obtencion del analogo de somatostatina octreotide.
DE69915160T DE69915160T2 (de) 1998-01-29 1999-01-27 Verfahren zur Herstellung des Somatostatin Analogons Octreotide
ES99500012T ES2217717T3 (es) 1998-01-29 1999-01-27 Procedimiento para la obtencion del analogo de somatostatina octreotide.
EP99500012A EP0953577B1 (en) 1998-01-29 1999-01-27 Procedure for obtaining the somatostatin analog, octreotide
US09/240,145 US6346601B1 (en) 1998-01-29 1999-01-29 Procedure for obtaining the somatostatin analog, octreotide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009800162A ES2144357B1 (es) 1998-01-29 1998-01-29 Procedimiento para la obtencion del analogo de somatostatina octreotide.

Publications (2)

Publication Number Publication Date
ES2144357A1 ES2144357A1 (es) 2000-06-01
ES2144357B1 true ES2144357B1 (es) 2000-12-16

Family

ID=8302556

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009800162A Expired - Lifetime ES2144357B1 (es) 1998-01-29 1998-01-29 Procedimiento para la obtencion del analogo de somatostatina octreotide.
ES99500012T Expired - Lifetime ES2217717T3 (es) 1998-01-29 1999-01-27 Procedimiento para la obtencion del analogo de somatostatina octreotide.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99500012T Expired - Lifetime ES2217717T3 (es) 1998-01-29 1999-01-27 Procedimiento para la obtencion del analogo de somatostatina octreotide.

Country Status (4)

Country Link
US (1) US6346601B1 (es)
EP (1) EP0953577B1 (es)
DE (1) DE69915160T2 (es)
ES (2) ES2144357B1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476186B1 (en) * 2000-05-23 2002-11-05 Institute Of Nuclear Energy Research Process for preparing octreotide and derivatives thereof
US7189856B2 (en) * 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands
ES2277640T3 (es) * 2002-02-27 2007-07-16 Ferring Bv Productos intermedios y metodos para preparar analogos de heptapeptido de oxitocina.
US6987167B2 (en) 2002-05-22 2006-01-17 Wockhardt Limited Process for production of the somatostatin analog, octreotide
CN100338090C (zh) * 2002-12-17 2007-09-19 常州市第四制药厂有限公司 生长抑素全合成新方法
ATE334998T1 (de) * 2003-04-07 2006-08-15 Novetide Ltd Verfahren zur herstellung cyclischer peptide
CA2458084A1 (en) * 2004-03-12 2005-09-12 Dalton Chemical Laboratories Inc. Novel process for octreotide synthesis
KR100998175B1 (ko) 2008-05-30 2010-12-03 애니젠 주식회사 소마토스타틴의 제조방법
TWI394585B (zh) * 2008-07-25 2013-05-01 Iner Aec Executive Yuan The magnetic fluid used for the development or treatment of peptides
WO2010089757A2 (en) 2008-11-07 2010-08-12 Usv Limited An improved process for synthesis of cyclic octapeptide
WO2013046233A2 (en) 2011-09-30 2013-04-04 Mylan Laboratories Ltd Process for the preparation of octreotide acetate
WO2013132505A1 (en) 2012-03-09 2013-09-12 Natco Pharma Limited Improved process for preparation of octreotide by solution phase peptide synthesis
CN112500450A (zh) * 2019-09-16 2021-03-16 翰宇药业（武汉）有限公司 一种奥曲肽的合成方法
CN112778400A (zh) * 2021-02-05 2021-05-11 合肥科生景肽生物科技有限公司 一种奥曲肽的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19375086I2 (de) 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
EP0824103A1 (en) * 1996-08-13 1998-02-18 Chang-Shinn Su Method for synthesis of Tyr-3-octreotide

Also Published As

Publication number Publication date
EP0953577B1 (en) 2004-03-03
EP0953577A1 (en) 1999-11-03
DE69915160D1 (de) 2004-04-08
ES2217717T3 (es) 2004-11-01
ES2144357A1 (es) 2000-06-01
DE69915160T2 (de) 2005-01-20
US6346601B1 (en) 2002-02-12

Similar Documents

Publication Publication Date Title
ES2144357B1 (es) Procedimiento para la obtencion del analogo de somatostatina octreotide.
LU90457I2 (fr) Refacto
IT1190891B (it) Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
DK2162462T3 (da) Cxc-chemokin-receptor-4 (cxcr4) antagonistisk polypeptid
ES2237356T1 (es) Procedimiento para la preparacion de peptidos ciclicos.
AR061097A1 (es) Procedimiento para sintetizar timosinas
BRPI0511005A (pt) peptìdeos oligoméricos e seu uso para o tratamento de infecções por hiv
NO20084002L (no) Peptider og peptid derivater savel som farmasoytiske sammensetninger inneholdende det samme
DE69827262D1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
ES2578798T3 (es) Método de ligación nativa
GB1508681A (en) Synthesis of peptides
ATE362769T1 (de) Lineare kationische peptide mit fungizider wirksamkeit
ATE412751T1 (de) Menschliche tak1 und für diese kodierende dna
ES2441197T3 (es) Método para la síntesis química de polipéptidos y proteínas
DK1474439T3 (da) Dipeptider og tripeptider med anti-inflammatorisk virkning
CO5090903A1 (es) Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea
DE69831584T2 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
Fauchere et al. Differential protection and selective deprotection in peptide synthesis
CN106749545A (zh) Gymnopeptide a和gymnopeptide b的制备方法
ATE201233T1 (de) Tgf-beta rii rezeptor nukleinsäuresequenz, dadurch kodiertes peptid, und verwendungen davon
Oh-uchi et al. The Influence of Protecting Groups on the β-Sheet-Structure Stability of Protected Peptides
FAUCHERE et al. and Selective Deprotection in Peptide Synthesis
Beyermann et al. Protected amino acid chlorides: Coupling reagents suitable for the most highly hindered systems
Semchuk et al. Minimization of side reactions during removal of the formyl protecting group from the ε-amino group of lysine

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000601

Kind code of ref document: A1

Effective date: 20000601

PC2A Transfer of patent

Owner name: BCN PEPTIDES, S.A.

Effective date: 20120905